Entering the December of 2018, near the end of the year, Meggle of Germany got CDMF of exipient! The final product of this year is SpheroLac 100 (registration no. : F20180000795) for screening lactose, and SorboLac 400 (registration no. : F20180000797) for grinding lactose. At this point, Meggle has a total of 15 lactose registration Numbers while continuously following up the requirements of Chinese laws and regulations.
In 1887, in Wasserburg, a small town near Munich, Meggle established a small but sophisticated dairy business. Up to now, Meggle has become the world's leading pharmaceutical lactose producer, with all kinds of pharmaceutical lactose required by customers. The rich product line of Meggle includes 8 lines and 27 specifications, covering all aspects from solid preparations (including tablets, capsules and granules) to powder preparations, dry powder inhalation and injection, many of which are unique to Meggle. In order to ensure optimal quality and batch stability, Meggle conducts product research and development, production and quality control in strict accordance with relevant requirements of Europe and the United States, which is also an important reason why Meggle has become a top global pharmaceutical company.
